Tags Reports - Allied Market Research

sale

Spine Biologics Market

P

2024

Spine Biologics Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global spine biologics market was valued at $3.1 billion in 2023, and is projected to reach $5.2 Billion by 2033, growing at a CAGR of 5.4% from 2024 to 2033

Report Code : A01625 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Clinical trials Market

U

2025

Clinical trials Market:

Report Summary The report aims to provide detailed insights on Clinical trials market and its phase, study design, application, service type at global, regional and country levels. The Clinical trials market is analyzed through two stage processes

Report Code : A10264 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Biologics Contract Development Market

U

2025

Biologics Contract Development Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Biologics are genetically engineered proteins which are originated from genes of human. Biologic drugs target the specific parts of the human immune system. Biologics are completely different from ...

Report Code : A13187 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Advanced Orthopedic Technologies Market

P

2024

Advanced Orthopedic Technologies Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global advanced orthopedic technologies market was valued at $58.1 billion in 2023, and is projected to reach $92.1 Billion by 2033, growing at a CAGR of 4.7% from 2024 to 2033

Report Code : A172235 | Pages : 233 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Glycomic Therapeutics Market

P

2024

Glycomic Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global glycomic therapeutics market was valued at $95.1 billion in 2023, and is projected to reach $405.7 billion by 2033, growing at a CAGR of 15.6% from 2024 to 2033.

Report Code : A324007 | Pages : 216 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Glycomics/Glycobiology Market by Product

P

2024

Glycomics/Glycobiology Market by Product : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global glycomics/glycobiology market was valued at $2.0 billion in 2023, and is projected to reach $7.8 billion by 2033, growing at a CAGR of 14.5% from 2024 to 2033.

Report Code : A324428 | Pages : 216 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Results for Tags: biologics

Filter by Region

Filter by Discounts

Filter by Category

The global spine biologics market was valued at $3.1 billion in 2023, and is projected to reach $5.2 Billion by 2033, growing at a CAGR of 5.4% from 2024 to 2033

Report Summary The report aims to provide detailed insights on Clinical trials market and its phase, study design, application, service type at global, regional and country levels. The Clinical trials market is analyzed through two stage processes

Biologics are genetically engineered proteins which are originated from genes of human. Biologic drugs target the specific parts of the human immune system. Biologics are completely different from ...

The global advanced orthopedic technologies market was valued at $58.1 billion in 2023, and is projected to reach $92.1 Billion by 2033, growing at a CAGR of 4.7% from 2024 to 2033

The global glycomic therapeutics market was valued at $95.1 billion in 2023, and is projected to reach $405.7 billion by 2033, growing at a CAGR of 15.6% from 2024 to 2033.

The global glycomics/glycobiology market was valued at $2.0 billion in 2023, and is projected to reach $7.8 billion by 2033, growing at a CAGR of 14.5% from 2024 to 2033.